InvestorsHub Logo
Followers 3
Posts 152
Boards Moderated 0
Alias Born 12/10/2013

Re: None

Thursday, 03/15/2018 9:01:27 AM

Thursday, March 15, 2018 9:01:27 AM

Post# of 852
How come this hasn't happen yet? See Below. We're going on six months now???? Wow!!!!!


Entest BioMedical Inc. Announces 3 Million Share Zander Therapeutics, Inc. Dividend to be Paid to Shareholders
9/29/2017

Dividend is Approximately 83% Payout of Zander's Issued and Outstanding Common Shares

SAN DIEGO, September 29, 2017

Entest BioMedical, Inc. (OTC:ENTB) today announced that its Board of Directors has authorized a distribution on a pro rata basis as a dividend in kind of 3,000,000 of the common shares of Zander Therapeutics, Inc. ("Dividend Shares"), a subsidiary of ENTB, to:
?
(a) Holders of record of the outstanding common shares of ENTB as of the record date
(b) Holders of record of the shares of any outstanding series of the preferred shares of ENTB as of the record date.

Entest BioMedical's Chairman & CEO, David Koos stated, "The record date is anticipated to be set as soon as possible after the Form S-1 registering the Dividend Shares under the Securities Act of 1933 is declared effective by the United States Securities and Exchange Commission (SEC). On a pro rata basis, both common and all classes of preferred shareholders will receive this dividend. The Company expects the registration statement to be filed within the next few days with the SEC."